IP Library Patent Application 11932961
Patent Application
App. No. 11/932,961

PROCESS FOR PREPARATION OF ALDONIC ACIDS AND DERIVATIVES THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/932,961
Abstract

A process for the preparation of L-gluconic acid or a salt thereof, comprises treating an aqueous solution of 6-bromo-6-deoxy-2,3-anhydro-D-manno-1,4-lactone with a base at a pH of at least 12 and at a temperature of 45 to 55° C. to obtain an aqueous solution of L-gluconic acid.

Claims (31)

1 . A process for preparing a compound, comprising:

reacting 2,6-dibromo-2,6-dideoxy-D-mannono-1,4-lactone with a Lewis base and a catalytic amount of water, to form 6-bromo-6-deoxy-2,3-anhydro-D-manno-1,4-lactone.

2 . The process of claim 1 , wherein the reacting is carried out in a solvent comprising a ketone.

3 . The process of claim 1 , wherein the catalytic amount of water is 0.05 to 2% by weight of a solvent in which the 6-bromo-6-deoxy-2,3-anhydro-D-manno-1,4-lactone is formed.

4 . The process of claim 1 , wherein the catalytic amount of water is 0.75 to 0.8% by weight of a solvent in which the 6-bromo-6-deoxy-2,3-anhydro-D-manno-1,4-lactone is formed.

5 . The process of claim 1 , wherein the Lewis base comprises at least one member selected from the group consisting of fluorides and carbonates.

6 . The process of claim 1 , wherein the Lewis base comprises potassium fluoride and potassium carbonate.

7 . The process of claim 1 , wherein the reacting is carried out at a temperature of 20 to 45° C.

8 . The process of claim 2 , wherein:

the catalytic amount of water is 0.05 to 2% by weight of the solvent,

the Lewis base comprises at least one member selected from the group consisting of fluorides and carbonates, and

the reacting is carried out at a temperature of 20 to 45° C.

9 . The process of claim 1 , further comprising forming L-glucose from the 6-bromo-6-deoxy-2,3-anhydro-D-manno-1,4-lactone.

10 . The process of claim 8 , further comprising forming L-glucose from the 6-bromo-6-deoxy-2,3-anhydro-D-manno-1,4-lactone.

11 . A process for preparing a compound, comprising:

reacting a bromohydrin with a Lewis base and a catalytic amount of water, to form an epoxide.

12 . The process of claim 11 , wherein the bromohydrin is α-lactone.

13 . The process of claim 11 , wherein the bromohydrin is an α-bromohydrin lactone.

14 . The process of claim 11 , wherein the bromohydrin is an α-bromohydrin aldonolactone.

15 . The process of claim 11 , wherein the reacting is carried out in a solvent comprising a ketone.

16 . The process of claim 11 , wherein the catalytic amount of water is 0.05 to 2% by weight of a solvent in which the epoxide is formed.

17 . The process of claim 11 , wherein the Lewis base comprises at least one member selected from the group consisting of fluorides and carbonates.

18 . The process of claim 11 , wherein the reacting is carried out at a temperature of 20 to 45° C.

19 - 25 . (canceled)

26 . A process for preparing a compound, comprising:

reacting 6-bromo-6-deoxy-2,3-anhydro-D-manno-1,4-lactone with a base at a pH of at least 12 and at a temperature of 45 to 55° C., to form L-gluconic acid or a salt thereof.

27 - 30 . (canceled)

31 . A process for preparing a compound, comprising:

reacting D-glucono-1,5-lactone or a salt thereof with a hydrogen halide at a temperature of from 40 to 60° C., to form a reaction mixture; and

adding methanol to the reaction mixture, to form 2,6-dibromo-2,6-dideoxy-D-mannono-1,4-lactone.

32 - 37 . (canceled)

Assignments (9)
TERMINATION AND RELEASE Recorded Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
PATENT SECURITY AGREEMENT Recorded Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 024684 FRAME 0127. ASSIGNOR(S) HEREBY CONFIRMS THE AXCAN PHARMA, INC. SHOULD BE CORRECTED TO READ AXCAN PHARMA US, INC.. Recorded May 10, 2013
From: C.B. FLEET COMPANY
To: AXCAN PHARMA US, INC.
Reel/Frame 030391/0901 →
CHANGE OF NAME Recorded Feb 17, 2012
From: AXCAN PHARMA INC.
To: APTALIS PHARMA CANADA INC.
Reel/Frame 027725/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2010
From: C.B. FLEET COMPANY
To: AXCAN PHARMA, INC.
Reel/Frame 024684/0127 →
RE-RECORD TO CORRECT THE NAME OF THE ASSIGNOR, PREVIOUSLY RECORDED ON REEL 020860 FRAME 0611. Recorded Jun 18, 2008
From: DEXTRA LABORATORIES LIMITED
To: C.B. FLEET COMPANY, INC.
Reel/Frame 021116/0292 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME PREVIOUSLY RECORDED ON REEL 020860 FRAME 0600 Recorded Jun 18, 2008
From: WEYMOUTH-WILSON, ALEXANDER CHARLES; CLARKSON, ROBERT
To: DEXTRA LABORATORIES LIMITED
Reel/Frame 021116/0411 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2008
From: WEYMOUTH-WILSON, ALEXANDER CHARLES; CLARKSON, ROBERT
To: DEXTRA LABORITIES LIMITED
Reel/Frame 020860/0600 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2008
From: DEXTRA LABORITIES LIMITED
To: C.B. FLEET COMPANY, INC.
Reel/Frame 020860/0611 →